The wrinkle wars are beginning to heat up. After decades of having only one source for anti-wrinkle therapy, there is finally a competitor to Botox for the treatment of facial wrinkles called Dysport. The introduction of Dysport now allows
Dr. Robinson to offer you an alternative neurotoxin for facial cosmetic applications.
The main active ingredient for
Dysport, as well as for
Botox, is a refined form of
botulinum toxin type A. The toxin acts as a neuromuscular blocker that inhibits muscle tension and spasming, which can create the appearance of facial wrinkles in the forehead, crow's feet around the eyes, and creases between the brows. Unlike Dermal fillers, Dysport and Botox injections are actually injected into muscles beneath the skin's surface. The refined toxin relaxes facial muscles, and causes the skin surface to smooth out as a result.
Although Botox and Dysport are both botulinum type A molecules, they are manufactured somewhat differently. As a result, they
have some subtle differences in their clinical effects. Some of the reported differences with Dysport are that it has a faster onset of action than Botox. Rather than waiting for up to a week for Botox to work, Dysport appears to work in just a day or so. Another important difference is that the effect of Dysport is reported to last longer than Botox, sometimes by a month or more. However, it should be pointed out that no studies have ever been done yet that compares Dysport to Botox in a head-to-head comparison. Therefore, the longer lasting benefits of Dysport are largely anecdotal, but may well be real. Apparently, fewer allergic reactions have been reported with Dysport because fewer antibodies react to the toxins, when compared to equal treatments of Botox. These benefits, coupled with reduced price, could give Dysport a clear advantage over Botox treatments.
Dysport has actually been distributed for cosmetic uses abroad for several years. Like Botox, Dysport got its start not as a cosmetic skin care treatment, but as a medical remedy for muscle spasms and movement disorders. The drug's benefited for aging skin were discovered as a pleasant side effect, and the Dysport movement took off from there.
Dysport came to the U.S. following the partnership of Dysport's manufacturer, Ipsen, with
Medicis, the pharmaceutical company that developed filler favorites
Restylane and
Perlane. Dysport was intended to be marketed under the brand name "Reloxin" for U.S. patients. However, the FDA ruling stated the treatment's original name, Dysport, would be used instead.
To schedule your Dysport consult with Dr. Robinson, call 770-667-3090!
